Apotex Targets C$24 IPO Price, Lifting Deal to C$1.3 Billion
Updated
Updated · Bloomberg · Jun 9
Apotex Targets C$24 IPO Price, Lifting Deal to C$1.3 Billion
2 articles · Updated · Bloomberg · Jun 9
Summary
Apotex Health is guiding investors to expect its Toronto IPO to price at C$24 later Tuesday, putting the generic drugmaker at the top of its marketed range.
C$24 is the high end of the C$20-to-C$24 range, and the company raised the expected proceeds after increasing the number of shares on offer late Monday.
C$1.3 billion would make the listing Canada's largest IPO since 2021, giving the deal broader significance beyond the company itself.